RESUMEN

Rotator cuff tears are common in middle-aged and elderly patients. Despite advances in the surgical repair of rotator cuff tears, the rates of recurrent tear remain high. This may be due to the complexity of the tendons of the rotator cuff, which contributes to an inherently hostile healing environment. During the past 20 years, there has been an increased interest in the use of biologics to complement the healing environment in the shoulder, in order to improve rotator cuff healing and reduce the rate of recurrent tears. The aim of this review is to provide a summary of the current evidence for the use of forms of biological augmentation when repairing rotator cuff tears.

Asunto(s)

Productos Biológicos , Lesiones del Manguito de los Rotadores , Cicatrización de Heridas , Humanos , Lesiones del Manguito de los Rotadores/cirugía , Productos Biológicos/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Manguito de los Rotadores/cirugía